Export

Ethionamide
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.5. Antituberculosis medicines
ATC codes: J04AD03
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis ICD11 code: ML32.00
INN
Ethionamide
Medicine type
Chemical agent
List type
Complementary
Formulations
Oral > Solid: 250 mg tablet ; 125 mg tablet (dispersible) (EMLc)
EML status history
First added in 1982 (TRS 685)
Removed in 1987 (TRS 770)
Added in 1999 (TRS 895)
Changed in 2003 (TRS 920)
Changed in 2007 (TRS 950)
Changed in 2013 (TRS 985)
Changed in 2019 (TRS 1021)
Changed in 2021 (TRS 1035)
Changed in 2023 (TRS 1049)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
protionamide (ATC codes: J04AD01)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Ethionamide
DrugBank
Ethionamide
Summary of evidence and Expert Committee recommendations
The Committee recommended deletion from the EML and/or EMLc of various formulations and strengths of amikacin (injection: 100 mg/2 mL (as sulfate) in 2 mL vial), ethambutol (Oral liquid: 25 mg/mL), ethionamide (tablet: 125 mg), isoniazid (oral liquid: 50 mg/5 mL), linezolid (powder for oral liquid: 100 mg/5 mL), p-aminosalicylic acid (granules: 4 g in sachet) and pyrazinamide (oral liquid: 30 mg/mL), noting that they are not optimal formulations and strengths for tuberculosis treatment.